Known hypersensitivity Previous serious allergic reaction (anaphylaxis, angioedema) to semaglutide or any pen/vial excipient
Currently, there are three FDA-approved oral GLP-1s on the market in the US: Rybelsus, which is approved for type 2 diabetes, the Wegovy pill, which is approved for weight loss, and Foundayo, which is also approved for weight loss
Finding the sweet spot
The blend offers several advantages over synthetic growth hormone: More natural pulsatile release Lower cost Fewer side effects Legal status (for research purposes) Maintains natural feedback mechanisms However, synthetic GH produces more dramatic results at higher doses
Furthermore, the long-term consequences of using glutathione in this manner are not fully understood
Risk assessment should consider patient age, smoking history, and presence of constitutional symptoms